REGULATION OF HEPATIC NA+/K+ -ATPASE BY PROTEIN KINASES

蛋白质激酶对肝脏 NA /K -ATP 酶的调节

基本信息

项目摘要

Ca2+-mobilizing hormones and glucagon stimulate hepatic Na+/K+-ATPase. In rat liver, this stimulation occurs fairly rapidly (i.e. less than 30 sec) and is not secondary to increased Na-influx. Evidence from several laboratories including our own has implicated the diacylglycerol/protein kinase C pathway (Ca2+-mobilizing hormones) and cAMP/protein kinase A pathway (glucagon) in the stimulation of the Na+/K+-ATPase by these agents. In view of the potential regulatory role of protein phosphorylation in hormone dependent activation of Na+/K+-ATPase, we propose to test hypothesis that Na+/K+-ATPase is phosphorylated and functionally regulated by two kinases in the regulation of this enzyme two specific aims will be undertaken: The first aim will be to characterize the effect of interventions, which specifically alter protein kinase C and cAMP-dependent protein kinase activity or inhibit protein phosphatases, on the activity of Na+/K+-ATPase as well as the extent of phosphorylation of Na+/K+-ATPase alpha and beta subunits. This will include pharmacologic manipulation of Na+/K+-ATPase activity and phosphorylation with specific activators of cAMP-dependent protein kinase and protein kinase C. The ability specific inhibitors of these two kinases to interrupt hormone dependent activation and phosphorylation of Na+/K+-ATPase will also be studied. Further we will seek to determine whether the protein phosphatase inhibitor, okadiac acid, will prolong or mimic activity and phosphorylation responses to hormones. Freshly isolated rat hepatocytes as well as cell cultures of hepatocytes with down-regulated protein kinase C activities will be utilized for these experiments. In all of the proposed studies, time and concentration dependent changes will be obtained in order to correlate the two responses. Ouabain-sensitive 86Rb+-uptake will be measured to monitor Na+/K+-ATPase enzymatic activity and Na+/K+-ATPase subunit phosphorylation will be evaluated by monitoring the incorporation of 32P into the alpha and beta subunits (i.e. the subunits will be immunoprecipitated from detergent extracts of hepatocytes with [32P] radioequilibrated ATP pools prior to polyacrylamide gel electrophoresis and autoradiography). Preliminary studies have established a two dimensional gel methodology which separates Na+/K+-ATPase subunits and antisera which recognize the subunits. The second aim of these studies is to identify any amino acid residues in Na+/K+-ATPase which are phosphorylated by these kinases and ascertain their location within the primary structure of the alpha- and beta-subunits. For this purpose, immunoprecipitated [32P]-phosphoproteins corresponding to the alpha and beta subunits will be partially hydrolyzed and subjected to phosphoamino acid analysis. I subsequent studies radiolabelled subunits will be subjected to proteolytic digestion prior to electrophoresis, Western blotting and sequence analysis of Na+/K+-ATPase subunits. The long term goals of this project are to elucidate the molecular mechanisms responsible for stimulation of Na+/K+-ATPase by hormones in order to determine their role in the regulation of liver metabolism.
Ca2+动员激素和胰高血糖素刺激肝Na+/K+- atp酶。在

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER JOHN LYNCH其他文献

CHRISTOPHER JOHN LYNCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER JOHN LYNCH', 18)}}的其他基金

Adipose Organ Transplant for Treatment of Maple Syrup Urine Disease
脂肪器官移植治疗枫糖浆尿病
  • 批准号:
    8281453
  • 财政年份:
    2011
  • 资助金额:
    $ 10.67万
  • 项目类别:
Adipose Organ Transplant for Treatment of Maple Syrup Urine Disease
脂肪器官移植治疗枫糖浆尿病
  • 批准号:
    8091967
  • 财政年份:
    2011
  • 资助金额:
    $ 10.67万
  • 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
  • 批准号:
    8034612
  • 财政年份:
    2010
  • 资助金额:
    $ 10.67万
  • 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
  • 批准号:
    8146903
  • 财政年份:
    2010
  • 资助金额:
    $ 10.67万
  • 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
  • 批准号:
    8474748
  • 财政年份:
    2010
  • 资助金额:
    $ 10.67万
  • 项目类别:
Mechanisms of drug side effects related to obesity and diabetes
肥胖和糖尿病相关药物副作用的机制
  • 批准号:
    8288238
  • 财政年份:
    2010
  • 资助金额:
    $ 10.67万
  • 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
  • 批准号:
    6748429
  • 财政年份:
    2003
  • 资助金额:
    $ 10.67万
  • 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
  • 批准号:
    7677993
  • 财政年份:
    2003
  • 资助金额:
    $ 10.67万
  • 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
  • 批准号:
    6874307
  • 财政年份:
    2003
  • 资助金额:
    $ 10.67万
  • 项目类别:
Role of Leucine Metabolism in Leucine Signaling
亮氨酸代谢在亮氨酸信号转导中的作用
  • 批准号:
    7920817
  • 财政年份:
    2003
  • 资助金额:
    $ 10.67万
  • 项目类别:

相似海外基金

Developing multitarget enzyme inhibitors as safe and effective anti-migraine treatments
开发多靶点酶抑制剂作为安全有效的抗偏头痛治疗方法
  • 批准号:
    10714658
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
  • 批准号:
    10395608
  • 财政年份:
    2021
  • 资助金额:
    $ 10.67万
  • 项目类别:
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
  • 批准号:
    10576908
  • 财政年份:
    2021
  • 资助金额:
    $ 10.67万
  • 项目类别:
The Development and Study of Novel Lipopeptide Antibiotics and Enzyme Inhibitors
新型脂肽抗生素和酶抑制剂的开发与研究
  • 批准号:
    RGPIN-2017-04233
  • 财政年份:
    2021
  • 资助金额:
    $ 10.67万
  • 项目类别:
    Discovery Grants Program - Individual
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
  • 批准号:
    10166534
  • 财政年份:
    2021
  • 资助金额:
    $ 10.67万
  • 项目类别:
Novel Enzyme Inhibitors in the Immune Evasion Repertoire of Staphylococcus aureus (Equipment Supplement)
金黄色葡萄球菌免疫逃逸的新型酶抑制剂(设备补充)
  • 批准号:
    10796329
  • 财政年份:
    2021
  • 资助金额:
    $ 10.67万
  • 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
  • 批准号:
    10259832
  • 财政年份:
    2020
  • 资助金额:
    $ 10.67万
  • 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
  • 批准号:
    10642850
  • 财政年份:
    2020
  • 资助金额:
    $ 10.67万
  • 项目类别:
The Development and Study of Novel Lipopeptide Antibiotics and Enzyme Inhibitors
新型脂肽抗生素和酶抑制剂的开发与研究
  • 批准号:
    RGPIN-2017-04233
  • 财政年份:
    2020
  • 资助金额:
    $ 10.67万
  • 项目类别:
    Discovery Grants Program - Individual
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
  • 批准号:
    10408178
  • 财政年份:
    2020
  • 资助金额:
    $ 10.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了